Page 197 - 磁共振成像2024年7期电子刊

综 述｜｜Reviews 磁共振成像 2024年7月第15卷第7期 Chin J Magn Reson Imaging, Jul, 2024, Vol. 15, No. 7

prognosis in pulmonary arterial hypertension[J]. JACC Cardiovasc Imaging, [28] YOON S, NAKAMORI S, AMYAR A, et al. Accelerated cardiac MRI
2023, 16(8): 1022-1034. DOI: 10.1016/j.jcmg.2023.02.007. cine with use of resolution enhancement generative adversarial inline
[11] PU L T, DIAO Y K, WANG J, et al. The predictive value of fast neural network[J/OL]. Radiology, 2023, 307(5): e222878 [2024-03-14].
semi-automated left atrial long-axis strain analysis for atrial fibrillation https://pubmed.ncbi.nlm.nih.gov/37249435/. DOI: 10.1148/radiol.222878.
in hypertrophic cardiomyopathy[J]. Eur Radiol, 2023, 33(1): 312-320. [29] MARTIN-ISLA C, CAMPELLO V M, IZQUIERDO C, et al. Deep
DOI: 10.1007/s00330-022-09020-x. learning segmentation of the right ventricle in cardiac MRI: the M&Ms
[12] BARBAROUX H, KUNZE K P, NEJI R, et al. Automated challenge[J]. IEEE J Biomed Health Inform, 2023, 27(7): 3302-3313.
segmentation of long and short axis DENSE cardiovascular magnetic DOI: 10.1109/JBHI.2023.3267857.
resonance for myocardial strain analysis using spatio-temporal [30] PUJADAS E R, RAISI-ESTABRAGH Z, SZABO L, et al. Prediction
convolutional neural networks[J/OL]. J Cardiovasc Magn Reson, 2023, of incident cardiovascular events using machine learning and CMR
25(1): 16 [2024-03-14]. https://pubmed.ncbi.nlm.nih.gov/36991474/. DOI: radiomics[J]. Eur Radiol, 2023, 33(5): 3488-3500. DOI: 10.1007/s00330-
10.1186/s12968-023-00927-y. 022-09323-z.
[13] TRENTI C, FEDAK P W M, WHITE J A, et al. Oscillatory shear stress [31] FAHMY A S, ROWIN E J, JAAFAR N, et al. Radiomics of late
is elevated in patients with bicuspid aortic valve and aortic regurgitation: a gadolinium enhancement reveals prognostic valueof myocardial scar
4D flow cardiovascular magnetic resonance cross-sectional study[J]. Eur heterogeneity in hypertrophic cardiomyopathy[J]. JACC Cardiovasc
Heart J Cardiovasc Imaging, 2024, 25(3): 404-412. DOI: 10.1093/ehjci/ Imaging, 2024, 17(1): 16-27. DOI: 10.1016/j.jcmg.2023.05.003.
jead283. [32] ARBELO E, PROTONOTARIOS A, GIMENO J R, et al. 2023 ESC
[14] WEISS E K, JARVIS K, MAROUN A, et al. Systolic reverse flow Guidelines for the management of cardiomyopathies[J]. Eur Heart J,
derived from 4D flow cardiovascular magnetic resonance in bicuspid 2023, 44(37): 3503-3626. DOI: 10.1093/eurheartj/ehad194.
aortic valve is associated with aortic dilation and aortic valve stenosis: [33] WANG J X, YANG S J, MA X, et al. Assessment of late gadolinium
a cross sectional study in 655 subjects[J/OL]. J Cardiovasc Magn enhancement in hypertrophic cardiomyopathy improves risk stratification
Reson, 2023, 25(1): 3 [2024-03-14]. https://pubmed.ncbi.nlm.nih.gov/ based on current guidelines[J]. Eur Heart J, 2023, 44(45): 4781-4792.
36698129/. DOI: 10.1186/s12968-022-00906-9. DOI: 10.1093/eurheartj/ehad581.
[15] PENG K, ZHANG X L, HUA T, et al. Evaluation of left ventricular [34] KIAOS A, DASKALOPOULOS G N, KAMPERIDIS V, et al.
blood flow kinetic energy in patients with hypertension by Quantitative late gadolinium enhancement cardiac magnetic resonance
four-dimensional flow cardiovascular magnetic resonance imaging: a and sudden death in hypertrophic cardiomyopathy: a meta-analysis[J].
preliminary study[J]. Eur Radiol, 2023, 33(7): 4676-4687. DOI: JACC Cardiovasc Imaging, 2024, 17(5): 489-497. DOI: 10.1016/j.
10.1007/s00330-023-09449-8. jcmg.2023.07.005.
[16] ASHKIR Z, JOHNSON S, LEWANDOWSKI A J, et al. Novel insights [35] YANG S J, ZHAO K K, YANG K, et al. Subendocardial involvement
into diminished cardiac reserve in non-obstructive hypertrophic as an underrecognized LGE subtype related to adverse outcomes in
cardiomyopathy from four-dimensional flow cardiac magnetic resonance hypertrophic cardiomyopathy[J]. JACC Cardiovasc Imaging, 2023,
component analysis[J]. Eur Heart J Cardiovasc Imaging, 2023, 24(9): 16(9): 1163-1177. DOI: 10.1016/j.jcmg.2023.03.011.
1192-1200. DOI: 10.1093/ehjci/jead074. [36] JOY G, KELLY C I, WEBBER M, et al. Microstructural and
[17] ZHAO X D, TAN R S, GARG P, et al. Age- and sex-specific reference microvascular phenotype of sarcomere mutation carriers and overt
values of biventricular flow components and kinetic energy by 4D flow hypertrophic cardiomyopathy[J]. Circulation, 2023, 148(10): 808-818.
cardiovascular magnetic resonance in healthy subjects[J/OL]. J DOI: 10.1161/CIRCULATIONAHA.123.063835.
Cardiovasc Magn Reson, 2023, 25(1): 50 [2024-03-14]. https://pubmed. [37] HEYDARI B, SATRIANO A, JEROSCH-HEROLD M, et al.
ncbi.nlm.nih.gov/37718441/. DOI: 10.1186/s12968-023-00960-x. 3-dimensional strain analysis ofHypertrophic cardiomyopathy: insights
[18] BISSELL M M, RAIMONDI F, AIT ALI L, et al. 4D Flow cardiovascular from the NHLBI international HCM registry[J]. JACC Cardiovasc
magnetic resonance consensus statement: 2023 update[J/OL]. J Cardiovasc Imaging, 2023, 16(4): 478-491. DOI: 10.1016/j.jcmg.2022.10.005.
Magn Reson, 2023, 25(1): 40 [2024-03-14]. https://pubmed.ncbi.nlm.nih. [38] XU Z Q, WANG J, CHENG W, et al. Incremental significance of
gov/37474977/. DOI: 10.1186/s12968-023-00942-z. myocardial oedema for prognosis in hypertrophic cardiomyopathy[J].
[19] PARK S, CHEN L Y, TOWNSEND J, et al. Simultaneous multi-VENC Eur Heart J Cardiovasc Imaging, 2023, 24(7): 876-884. DOI: 10.1093/
and simultaneous multi-slice phase contrast magnetic resonance ehjci/jead065.
imaging[J]. IEEE Trans Med Imaging, 2020, 39(3): 742-752. DOI: [39] LI S, WANG Y N, YANG W J, et al. Cardiac MRI risk stratification for
10.1109/TMI.2019.2934422. dilated cardiomyopathy with left ventricular ejection fraction of 35% or
[20] ROOIJAKKERS M J P, VAN WELY M H, HABETS J, et al. A novel higher[J/OL]. Radiology, 2023, 306(3): e213059 [2024-03-14]. https://
approach in the assessment of paravalvular regurgitation after pubmed.ncbi.nlm.nih.gov/36318031/. DOI: 10.1148/radiol.213059.
transcatheter aortic valve replacement using cardiac magnetic resonance [40] LI Y J, XU Y W, LI W H, et al. Cardiac MRI to predict sudden cardiac
imaging[J/OL]. Eur Heart J Cardiovasc Imaging, 2023, 24(Supplement_1): death risk in dilated cardiomyopathy[J/OL]. Radiology, 2023, 307(3):
jead119.338 [2024-03-14]. https://academic.oup.com/ehjcimaging/article/ e222552 [2024-03-14]. https://pubmed. ncbi. nlm. nih. gov/36916890/.
24/Supplement_1/jead119.338/7198713. DOI: 10.1093/ehjci/jead119.338.
DOI: 10.1148/radiol.222552.
[21] BUSTAMANTE M, VIOLA F, ENGVALL J, et al. Automatic [41] ZHOU D, ZHU L Y, WU W C, et al. A novel cardiac magnetic
time-resolved cardiovascular segmentation of 4D flow MRI using deep resonance-based personalized risk stratification model in dilated
learning[J]. J Magn Reson Imaging, 2023, 57(1): 191-203. DOI:
10.1002/jmri.28221. cardiomyopathy: a prospective study[J]. Eur Radiol, 2024, 34(6):
[22] ROTHENBERGER S M, PATEL N M, ZHANG J C, et al. Automatic 4053-4064. DOI: 10.1007/s00330-023-10415-7.
4D flow MRI segmentation using the standardized difference of means [42] GAO Y, WANG H P, LIU M X, et al. Early detection of myocardial
velocity[J]. IEEE Trans Med Imaging, 2023, 42(8): 2360-2373. DOI: fibrosis in cardiomyopathy in the absence of late enhancement: role of
10.1109/TMI.2023.3251734. T1 mapping and extracellular volume analysis[J]. Eur Radiol, 2023,
[23] 崔亚东, 郑冲, 谷珊珊, 等 . 一体化 PET/MR 对缺血性心脏病心肌活 33(3): 1982-1991. DOI: 10.1007/s00330-022-09147-x.
性 的 评 估 价 值 [J]. 中 华 核 医 学 与 分 子 影 像 杂 志 , 2023, 43(9): [43] IOANNOU A, PATEL R K, RAZVI Y, et al. Multi-imaging
513-517. DOI: 10.3760/cma.j.cn321828-20220609-00182. characterization of cardiac phenotype in different TypesofAmyloidosis[J].
CUI Y D, ZHENG C, GU S S, et al. Assessment of myocardial JACC Cardiovasc Imaging, 2023, 16(4): 464-477. DOI: 10.1016/j.
viability in ischemic heart disease by integrated PET/MR[J]. Chin J jcmg.2022.07.008.
Nucl Med Mol Imag, 2023, 43(9): 513-517. DOI: 10.3760/cma. j. [44] IOANNOU A, PATEL R K, MARTINEZ-NAHARRO A, et al.
cn321828-20220609-00182. Tracking multiorgan treatment response in systemic AL-amyloidosis
68
[24] ZHANG M, QUAN W W, ZHU T Q, et al. Ga]Ga-DOTA-FAPI-04 with cardiac magnetic resonance derived extracellular volume mapping[J].
PET/MR in patients with acute myocardial infarction: potential role of JACC Cardiovasc Imaging, 2023, 16(8): 1038-1052. DOI: 10.1016/j.
predicting left ventricular remodeling[J]. Eur J Nucl Med Mol jcmg.2023.02.019.
Imaging, 2023, 50(3): 839-848. DOI: 10.1007/s00259-022-06015-0. [45] IOANNOU A, PATEL R K, MARTINEZ-NAHARRO A, et al.
[25] 王梅云 . 磁共振成像人工智能的研究现状及发展前景[J]. 磁共振成 Tracking treatment response in cardiac light-chain amyloidosis with
像, 2023, 14(3): 1-5. DOI: 10.12015/issn.1674-8034.2023.03.001. native T1 mapping[J]. JAMA Cardiol, 2023, 8(9): 848-852. DOI:
WANG M Y. Research status and development prospect of magnetic 10.1001/jamacardio.2023.2010.
resonance imaging artificial intelligence[J]. Chin J Magn Reson Imag, [46] VIRANI S S, NEWBY L K, ARNOLD S V, et al. 2023 AHA/ACC/
2023, 14(3): 1-5. DOI: 10.12015/issn.1674-8034.2023.03.001. ACCP/ASPC/NLA/PCNA guideline for the management of patients
[26] OHTA Y, TATEISHI E, MORITA Y, et al. Optimization of null point in with chronic coronary disease: a report of the American heart association/
Look-Locker images for myocardial late gadolinium enhancement american college of cardiology joint committee on clinical practice
imaging using deep learning and a smartphone[J]. Eur Radiol, 2023, guidelines[J/OL]. Circulation, 2023, 148(9): e9-e119 [2024-03-14]. https://
33(7): 4688-4697. DOI: 10.1007/s00330-023-09465-8. pubmed.ncbi.nlm.nih.gov/37471501/. DOI: 10.1161/CIR.0000000000001168.
[27] WU X, DENG L P, LI W J, et al. Deep learning-based acceleration of [47] BYRNE R A, ROSSELLO X, COUGHLAN J J, et al. 2023 ESC
compressed sensing for noncontrast-enhanced coronary magnetic Guidelines for the management of acute coronary syndromes[J]. Eur
resonance angiography in patients with suspected coronary artery Heart J Acute Cardiovasc Care, 2024, 13(1): 55-161. DOI: 10.1093/
disease[J]. J Magn Reson Imaging, 2023, 58(5): 1521-1530. DOI: 10.1002/ ehjacc/zuad107.
jmri.28653. （下转第215页）
·190 · https://www.chinesemri.com